Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Immunol ; 236(1-2): 167-70, 2005.
Article in English | MEDLINE | ID: mdl-16165112

ABSTRACT

We have directly compared the use of a CD77 antibody with the binding subunit of Shiga-like toxin 1, Verotoxin 1, and (Stx1B) for delineation on human tonsil cells. We determined that the Stx1B produced a greater intensity of staining than the CD77 antibody, allowing three sub-populations of germinal centre cells to be seen. The populations express high, medium, and low levels of globotriaosylceramide as determined by the binding of the Stx1B reagent. The strong staining patterns of Stx1B suggest that it may be useful in defining germinal center B cell populations.


Subject(s)
Shiga Toxins/immunology , Trihexosylceramides/immunology , Antibodies, Monoclonal/immunology , B-Lymphocytes/metabolism , Evaluation Studies as Topic , Flow Cytometry/methods , Germinal Center/cytology , Germinal Center/metabolism , Humans , Palatine Tonsil/immunology , Shiga Toxins/metabolism , Trihexosylceramides/metabolism
2.
Hum Immunol ; 60(2): 127-39, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10027780

ABSTRACT

We have characterized the T lymphocyte population of the human neonate in respect of the expression of phenotypic profiles for naive, memory and differentiated populations. We have examined the response of the neonate T cell to the superantigen Staphylococcus enterotoxin B (SEB) and compared the response to T cells from healthy adults. We found that the primary response to SEB is equivalent in neonates and adults but that the secondary response demonstrates hyporesponsiveness in the neonate that is more profound than in adults. This response was associated with increased expression of CD25; the alpha chain of the IL-2 receptor, equivalent to that seen in responding cells from adults. A modest increased expression of CD122 and CD132, the beta and gamma chains of the IL-2 receptor, was also observed. There was no increase in the IL-4 receptor (CD124). The hyporesponsive neonate T cells proliferated in response to exogenous IL-2 but the response was less than none SEB treated cells. The neonate cells did not respond to IL-4. We also examined the expression of MHC class II molecules on SEB stimulated cells and found that both neonate and adult T cells upregulate MHC class II to a similar degree. The difference in the hyporesponsive cells appears to result in part from a lower production of IL-2 and in part from a lower ability of cord cells to respond to IL-2. Since the stimulated cord cells expressed IL-2 receptor at the same levels as similarly treated adult cells; there may be differences in down stream signaling pathways.


Subject(s)
Enterotoxins/immunology , Staphylococcus aureus/immunology , Superantigens/immunology , T-Lymphocytes/immunology , Adult , Antigens, CD/immunology , Fetal Blood/cytology , HLA-D Antigens/biosynthesis , Humans , Immunophenotyping , Interleukin-2/biosynthesis , Interleukin-2/immunology , Interleukin-2/pharmacology , Interleukin-4/immunology , Interleukin-4/pharmacology , Receptors, Interleukin-2/immunology , T-Lymphocytes/drug effects
3.
Rheumatol Int ; 19(1-2): 31-4, 1999.
Article in English | MEDLINE | ID: mdl-10651079

ABSTRACT

The shared rheumatoid epitope (SRE) on the MHC class II antigen-presenting molecule constitutes a probable genetic risk factor for the occurrence of rheumatoid arthritis (RA) and may also determine disease severity. We have used a novel flow cytometric technique to determine the SRE in over 500 predominantly Caucasian patients attending a general rheumatology clinic. This technique has been validated against a polymerase chain reaction (PCR)/SSO molecular method. The SRE was observed in 90% of patients with Felty's syndrome (n = 10) and 75% of patients with RA (n = 178) as compared with 39% of patients with osteoarthritis or non-inflammatory rheumatic disorders (n = 73). Thus, the SRE determined by this method has a sensitivity for RA of 0.75, a specificity of 0.62 and an estimated positive predictive value of 0.02. In our RA cohort, there was no correlation between the functional outcome (health assessment questionnaire score) and SRE status. In conclusion, the determination of the SRE status by a flow cytometric method was found to have only modest sensitivity and specificity for RA; furthermore, the SRE did not correlate with functional outcomes. The clinical utility of the SRE assay is yet to be defined.


Subject(s)
Arthritis, Rheumatoid/pathology , Arthritis, Rheumatoid/physiopathology , Female , Flow Cytometry , Humans , Male , Middle Aged , Prognosis , Reproducibility of Results , Time Factors
4.
Hum Immunol ; 59(10): 615-24, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9757943

ABSTRACT

IL-2 receptor is expressed at low levels on adult blood lymphocytes, and at lower levels on cord blood cells. IL-2 receptor alpha and beta chain expression increases gradually from 0-18 months of age. The level of soluble CD25 (IL-2 receptor alpha chain) has been reported to be elevated in cord blood. Quantitative RT-PCR showed that adult cells express 10 times as much CD25 mRNA as cord cells. Cord plasma showed only a marginal ability to strip CD25 from the membrane. To assess the functional consequences of low IL-2 receptor expression, cord and adult cells were activated in vitro. The response was stimulus-dependent, but cord cells upregulated CD25 readily. Cord and adult cells proliferated in an IL-2-dependent assay to a similar extent. Infants suffering acute infection showed marginally higher levels of membrane CD25 expression than infants without overt infection. Thus neonatal and infant lymphocytes express lower levels of IL-2 receptors than adult cells, reflecting lower mRNA concentrations at least for CD25; they are able to up-regulate receptors in response to in vitro stimulation and are able to respond in vitro to IL-2-dependent stimulation; however in vivo there may be a dampening down of the IL-2 system in infancy.


Subject(s)
Interleukin-2/immunology , Receptors, Interleukin-2/biosynthesis , Adult , Age Factors , Communicable Diseases/immunology , Down-Regulation , Fetal Blood/immunology , Humans , Infant , Infant, Newborn , Infections/immunology , Leukocytes, Mononuclear/immunology , Lymphocyte Activation , RNA, Messenger/analysis , Receptors, Interleukin-2/genetics , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...